Richard A. Morgan

Oak Ridge National Laboratory — United States

Medicine · Health Sciences

63h-index34.5kcitations253works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(99), Immunotherapy and Immune Responses(73), Virus-based gene therapy research(69), CRISPR and Genetic Engineering(37), RNA Interference and Gene Delivery(36)

Publications248 total

Omics Integration Uncovers Mechanisms Associated with HIV Viral Load and Potential Therapeutic Insights
2025Open Access
Dopaminergic Therapies May Decrease Risk of Early and Intermediate Non-exudative Age-related Macular Degeneration Progression
Ophthalmic surgery, lasers & imaging retina·2025· 1 cited
A Versatile B Cell Engineering Platform Enables Development of B Cell Medicines for Sustained Delivery of Therapeutic Biologics
Blood·2024
<i>In vivo</i> tracking of <i>ex vivo</i> generated <sup>89</sup> Zr-oxine labeled plasma cells by PET in a non-human primate model
2024Open Access
Development of an precision gene engineered B cell medicine that produces highly active and sustained levels of acid sphingomyelinase for the treatment of Neimann-Pick disease
Molecular Genetics and Metabolism·2024
Neuromodulation Techniques in Chronic Refractory Coccydynia: A Narrative Review
Pain and Therapy·2024· 5 citedOpen Access
Development of an <i>Ex Vivo</i> Precision Gene Engineered B Cell Medicine That Produces Active and Sustained Levels of FIX for the Treatment of Hemophilia B
Blood·2023· 4 cited
Data from CpG Island Methylator Phenotype–Positive Tumors in the Absence of &lt;i&gt;MLH1&lt;/i&gt; Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis
2023Open Access
Data from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Supplementary Table 2 from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Data from Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer
2023Open Access
Supplementary Figure S1 from Development of Human Anti-Murine T-Cell Receptor Antibodies in Both Responding and Nonresponding Patients Enrolled in TCR Gene Therapy Trials
2023Open Access
Supplementary Table 2 from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Supplementary Table 3 from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Supplemental figure 5 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Data from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Supplementary Table 3 from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
Data from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Figure 2 from CpG Island Methylator Phenotype–Positive Tumors in the Absence of &lt;i&gt;MLH1&lt;/i&gt; Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis
2023Open Access
Supplementary Table 4 from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Steven A. Rosenberg(29), Zhili Zheng(13), Nicholas P. Restifo(12), Mark E. Dudley(9), Steven A. Feldman(8), Paul F. Robbins(8), Zhiya Yu(8), James C. Yang(7), Yangbing Zhao(6), Marybeth S. Hughes(5), W. French Anderson(5), Cyrille J. Cohen(5), Sid P. Kerkar(5), Christine A. Iacobuzio–Donahue(4), Ralph H. Hruban(4), Richard M. Sherry(4), Udai S. Kammula(4), Kenneth Cornetta(4), Dhanalakshmi Chinnasamy(4), David K. Chang(3)